DC in multiple myeloma immunotherapy

Author： Turtle CJ   Brown RD   Joshua DE   Hart DNJ  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.6, Iss.2, 2004-04, pp. : 128-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma

By Guardino Ae   Rajapaksa R   Ong Kh   Sheehan K   Levy R  

Cytotherapy, Vol. 8, Iss. 3, 2006-05 ,pp. : 277-289

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Meningeal Involvement in Multiple Myeloma

By  

Acta Cytologica, Vol. 40, Iss. 3, 2011-09 ,pp. : 571-575

Karger

Access to resources Recommend Favorite

DC-based immunotherapy of B-cell malignancies

By Reichardt Vl   Brossart Peter  

Cytotherapy, Vol. 6, Iss. 1, 2004-01 ,pp. : 62-67

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Multiple Myeloma with Monoclonal Surface Immunoglobulin Expression

By  

Acta Cytologica, Vol. 40, Iss. 2, 2011-09 ,pp. : 358-362

Karger

Access to resources Recommend Favorite

Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma

By Wu Jy   Ernstoff Ms   Hill Jm   Cole B   Meehan Kr  

Cytotherapy, Vol. 8, Iss. 2, 2006-05 ,pp. : 141-148

Ashgate Publishing Ltd

Access to resources Recommend Favorite